Trajan Group Holdings Limited (ASX:TRJ)
0.4970
-0.0130 (-2.55%)
Mar 5, 2026, 11:48 AM AEST
Trajan Group Holdings Revenue
Trajan Group Holdings had revenue of 84.06M AUD in the half year ending December 31, 2025, with 10.01% growth. This brings the company's revenue in the last twelve months to 169.52M, up 6.20% year-over-year. In the fiscal year ending June 30, 2025, Trajan Group Holdings had annual revenue of 166.46M with 7.38% growth.
Revenue (ttm)
169.52M
Revenue Growth
+6.20%
P/S Ratio
0.46
Revenue / Employee
269.07K
Employees
650
Market Cap
77.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 166.46M | 11.44M | 7.38% |
| Jun 30, 2024 | 155.02M | -7.13M | -4.40% |
| Jun 30, 2023 | 162.15M | 54.58M | 50.74% |
| Jun 30, 2022 | 107.57M | 31.01M | 40.49% |
| Jun 30, 2021 | 76.57M | 4.72M | 6.56% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.10B |
| Sigma Healthcare | 9.55B |
| Cochlear | 2.34B |
| Pro Medicus | 240.57M |
| Mach7 Technologies | 29.69M |
| Radiopharm Theranostics | 16.28M |
| PharmX Technologies | 7.65M |
| Alterity Therapeutics | 6.64M |